Vericel Corp is a recognised name in the biotech and healthcare sector, specialising in promoting advanced therapies that aid patient care. Known for its diligence and innovation, Vericel operates across many international territories, aiming to address serious medical needs worldwide.
Vericel engages in the research, development, manufacture and distribution of advanced cell therapies and other treatment services for sports medicine and severe burn care. Its portfolio includes breakthrough products such as MACI and Epicel.
Add VCEL stock to your eToro watchlist to monitor the share price changes.